Skip to main content
Caplight Logo









Astratus Limited

Astratus Limited

Private
ReadingHealthcare & Life Scienceshttps://astratus.co.uk/

Last Round

Seed

Jun 4, 2026

Total Funding Raised

$2.42M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Astratus Limited is a healthtech company that develops rapid, high-throughput antimicrobial susceptibility testing platforms for human and veterinary diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Precision Medicine, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

antimicrobial susceptibility testingASTrapid diagnosticsmicrobiology testingantimicrobial resistanceAMRclinical microbiologydiagnostic instrumentationmicrocapillary technologylab automationdiagnostic consumablesbiofilm researchpoint of care testingPOCTveterinary diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Astratus Limited Comparables

Compare Astratus Limited with similar companies based on industry and business-model similarity.

Astratus Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iFAST Diagnostics
88%
FASTinov
86%
Astek Diagnostics
85%

Astratus Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 4, 2026
Early FundingMar 12, 2026

Key People

Founding team and executive leadership

Alexander Edwards

Co-Founder and CTO

Founding Team

Julie Hart

Chief Medical Officer Co-Founder

Founding Team

Oliver Hancox

Chief Executive Officer

Executive Team

Astratus Limited Investors

Notable investors and investment history

Astratus Limited investors
InvestorRounds
Jenson VenturesSeed
Henley Business AngelsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 4, 2026

    $520K round from Jenson Ventures and Henley Business Angels

Astratus Limited Filings

Explore SEC and related filing metadata, where available.

Astratus Limited filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Astratus Limited's valuation, stock price, and market status.

Is Astratus Limited a public or private company?

Astratus Limited is a private company.

What is the current stock price of Astratus Limited?

Astratus Limited is a private company with no public stock price. No recent secondary market data is available.

How much is Astratus Limited worth (valuation)?

Valuation information for Astratus Limited is not publicly available.

Can I buy Astratus Limited stock?

Astratus Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Astratus Limited's last funding round?

Astratus Limited's most recent funding round was Seed on June 4, 2026.

Who are the main investors in Astratus Limited?

Key investors in Astratus Limited include Jenson Ventures, Henley Business Angels.

Will Astratus Limited IPO soon?

No public IPO plans have been announced for Astratus Limited.

How can I track Astratus Limited secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Astratus Limited's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersReading
Employee Range7
Year Founded2024
Last FundingJun 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?